{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:29:03Z","timestamp":1762100943829},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/fjc.0b013e3181b04cc5","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T07:13:28Z","timestamp":1252998808000},"page":"204-212","source":"Crossref","is-referenced-by-count":10,"title":["Adenosine-A1 Receptors Activation Restores the Suppressed Cardioprotective Effects of Ischemic Preconditioning in Hyperhomocysteinemic Rat Hearts"],"prefix":"10.1097","volume":"54","author":[{"given":"Pitchai","family":"Balakumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsimran","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu B","family":"Anand-Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1755-6783.43071","article-title":"Inhospital cardiovascular morbidity and mortality in the department of internal medicine at CHU Kigali (Rwanda).","volume":"1","author":"Amendezo","year":"2008","journal-title":"Ann Tropic Med Public Health"},{"key":"R2-5-20210208","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium.","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"R3-5-20210208","doi-asserted-by":"crossref","first-page":"H700","DOI":"10.1152\/ajpheart.1993.265.2.H700","article-title":"Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury.","volume":"265","author":"Defily","year":"1993","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R4-5-20210208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0165-6147(00)01483-8","article-title":"Ischaemic preconditioning of the vasculature: An overlooked phenomenon for protecting the heart.","volume":"21","author":"Rubino","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"R5-5-20210208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.phrs.2008.05.006","article-title":"Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: What could be the next footstep?","volume":"57","author":"Balakumar","year":"2008","journal-title":"Pharmacol Res"},{"key":"R6-5-20210208","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2008.10.029","article-title":"Preconditioning and postconditioning: Underlying mechanisms and clinical application.","volume":"204","author":"Hausenloy","year":"2009","journal-title":"Atherosclerosis"},{"key":"R7-5-20210208","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/physrev.00009.2003","article-title":"Preconditioning the myocardium: From cellular physiology to clinical cardiology.","volume":"83","author":"Yellon","year":"2003","journal-title":"Physiol Rev"},{"key":"R8-5-20210208","first-page":"353","article-title":"Ischaemic preconditioning: From molecular characterization to clinical application-Part I.","volume":"62","author":"Riksen","year":"2004","journal-title":"Neth J Med"},{"key":"R9-5-20210208","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.RES.87.10.845","article-title":"Myocardial KATP channels in preconditioning.","volume":"87","author":"Rourke","year":"2000","journal-title":"Circ Res"},{"key":"R10-5-20210208","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.RES.0000247029.31997.a4","article-title":"Signaling mechanisms in ischemic preconditioning. Interaction of PKC and Mito KATP in the inner membrane of mitochondria.","volume":"99","author":"Ardehali","year":"2006","journal-title":"Circ Res"},{"key":"R11-5-20210208","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardiores.2006.01.017","article-title":"Survival kinases in ischemic preconditioning and postconditioning.","volume":"70","author":"Hausenloy","year":"2006","journal-title":"Cardiovas Res"},{"key":"R12-5-20210208","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cardiores.2007.04.022","article-title":"Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.","volume":"75","author":"Lim","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R13-5-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1358\/mf.2009.31.2.1357292","article-title":"Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.","volume":"31","author":"Balakumar","year":"2009","journal-title":"Meth Find Exp Clin Pharmacol"},{"key":"R14-5-20210208","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1248\/yakushi.129.523","article-title":"Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.","volume":"129","author":"Singh","year":"2009","journal-title":"Yakugaku Zasshi"},{"key":"R15-5-20210208","doi-asserted-by":"crossref","first-page":"H441","DOI":"10.1152\/ajpheart.00589.2005","article-title":"Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating AKT.","volume":"290","author":"Solenkova","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R16-5-20210208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(00)00875-X","article-title":"Role of adenosine and glycogen in ischemic preconditioning of rat hearts.","volume":"414","author":"De Jonge","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R17-5-20210208","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00395-007-0687-7","article-title":"Adenosine: Trigger and mediator of cardioprotection.","volume":"103","author":"Cohen","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"R18-5-20210208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)01611-9","article-title":"Preconditioning of rat hearts by adenosine A1 or A3 receptor activation.","volume":"441","author":"De Jonge","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R19-5-20210208","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(99)00493-3","article-title":"Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation.","volume":"35","author":"Miura","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R20-5-20210208","doi-asserted-by":"crossref","first-page":"H2322","DOI":"10.1152\/ajpheart.00474.2002","article-title":"Ach and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases.","volume":"238","author":"Krieg","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R21-5-20210208","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.yjmcc.2004.08.001","article-title":"Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.","volume":"37","author":"Germack","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R22-5-20210208","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.CIR.0000027586.64231.1B","article-title":"Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function.","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"R23-5-20210208","first-page":"1001","article-title":"Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia.","volume":"43","author":"Riksen","year":"2005","journal-title":"Chem Lab Med"},{"key":"R24-5-20210208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.0000150651.85907.69","article-title":"Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia.","volume":"25","author":"Riksen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-5-20210208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cvr\/27.1.18","article-title":"Role of adenosine and its interaction with adrenoceptor activity in ischaemic and reperfusion injury of the myocardium.","volume":"27","author":"Kitakaze","year":"1993","journal-title":"Cardiovasc Res"},{"key":"R26-5-20210208","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0008-6363(03)00462-0","article-title":"Potential role for adenosine in the pathogenesis of vascular complications of hyperhomocysteinemia.","volume":"59","author":"Riksen","year":"2003","journal-title":"Cardiovas Res"},{"key":"R27-5-20210208","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01812150","article-title":"Untersuchungen am uberlebenden Saugethierherzen.","volume":"61","author":"Langendorff","year":"1895","journal-title":"Pflugers Archiv"},{"key":"R28-5-20210208","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcp\/61.1.108","article-title":"A comparison of serum versus heparinized plasma for routine chemistry tests.","volume":"61","author":"Lum","year":"1974","journal-title":"Am J Clin Pathol"},{"key":"R29-5-20210208","first-page":"435","article-title":"Approved recommendation of IFCC methods for the measurements of catalytic concentration of enzymes. VII: IFCC method for creatine kinase (ATP: creatine N-phosphotransferase EC 2.7.3.2).","volume":"29","author":"Horder","year":"1991","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"R30-5-20210208","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-8703(81)90226-X","article-title":"Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.","volume":"101","author":"Fishbein","year":"1981","journal-title":"Am Heart J"},{"key":"R31-5-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00230887","article-title":"Decrease of myocardial infarct size with desferrioxamine: Possible role of oxygen free radicals in its ameliorative effect.","volume":"113","author":"Chopra","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"R32-5-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/phrs.1999.0501","article-title":"Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.","volume":"40","author":"Parikh","year":"1999","journal-title":"Pharmacol Res"},{"key":"R33-5-20210208","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Analytical Biochem"},{"key":"R34-5-20210208","first-page":"882","article-title":"Improved method for the determination of blood glutathione.","volume":"61","author":"Beutler","year":"1963","journal-title":"J Lab Clin Med"},{"key":"R35-5-20210208","first-page":"267","article-title":"The diagnosis of perioperative myocardial infarction in heart surgery.","volume":"60","author":"Gonzalez-Hermosillo","year":"1990","journal-title":"Arch Inst Cardiol Mex"},{"key":"R36-5-20210208","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1010-7940(01)00602-9","article-title":"Differential effect of preconditioning on post-ischemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts.","volume":"19","author":"Efstathiou","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"R37-5-20210208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/phrs.1997.0174","article-title":"Effect of amiloride a Na+\/H+ exchange inhibitor on cardioprotective effect of ischaemic preconditioning: Possible involvement of resident cardiac mast cells.","volume":"36","author":"Kaur","year":"1997","journal-title":"Pharmacol Res"},{"key":"R38-5-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(00)00582-3","article-title":"Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.","volume":"406","author":"Sharma","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R39-5-20210208","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/FJC.0b013e31817ae60f","article-title":"Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats.","volume":"51","author":"Singh","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"R40-5-20210208","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/154.4.348","article-title":"Correlates of markers of oxidative status in the general population.","volume":"154","author":"Trevisan","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R41-5-20210208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","article-title":"Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.","volume":"35","author":"Faraci","year":"2004","journal-title":"Stroke"},{"key":"R42-5-20210208","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","article-title":"Status of myocardial antioxidants in ischemia-reperfusion injury.","volume":"47","author":"Dhalla","year":"2000","journal-title":"Cardiovas Res"},{"key":"R43-5-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-2-1","article-title":"Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury.","volume":"2","author":"Banerjee","year":"2002","journal-title":"BMC Pharmocol"},{"key":"R44-5-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.105.088336","article-title":"The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly (ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.","volume":"315","author":"Palfi","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R45-5-20210208","doi-asserted-by":"crossref","first-page":"491","DOI":"10.33549\/physiolres.930664","article-title":"Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes.","volume":"54","author":"Sahna","year":"2005","journal-title":"Physiol Res"},{"key":"R46-5-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/107424840501000101","article-title":"Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial-myocyte uncoupling.","volume":"10","author":"Tyagi","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R47-5-20210208","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.0000061735.85377.40","article-title":"Increased superoxide production in coronary arteries in hyperhomocysteinemia: Role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase.","volume":"23","author":"Ungvari","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R48-5-20210208","first-page":"569","article-title":"Ischemic preconditioning experimental facts and clinical perspective.","volume":"50","author":"Post","year":"2002","journal-title":"Minerva Cardioangiol"},{"key":"R49-5-20210208","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF00175797","article-title":"2-Chloro-N6-cyclopentyladenosine: A highly selective agonist at A1 adenosine receptors.","volume":"337","author":"Lohse","year":"1988","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"R50-5-20210208","first-page":"1305","article-title":"Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.","volume":"44","author":"Monopoli","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"R51-5-20210208","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1254\/jjp.86.265","article-title":"Adenosine, oxidative stress and cytoprotection.","volume":"86","author":"Ramkumar","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"R52-5-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1510\/icvts.2006.136317","article-title":"The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart.","volume":"6","author":"Hochhauser","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R53-5-20210208","first-page":"699","article-title":"Interstitial adenosine and cellular metabolism during -adrenergic stimulation of the in situ rabbit heart.","volume":"31","author":"Headrick","year":"1996","journal-title":"Cardiovas Res"},{"key":"R54-5-20210208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(01)00358-3","article-title":"Adenosine, adenosine receptors and myocardial protection: An updated review.","volume":"52","author":"Mubagwa","year":"2001","journal-title":"Cardiovas Res"},{"key":"R55-5-20210208","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0008-6363(02)00455-8","article-title":"Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning?","volume":"55","author":"Haunsenloy","year":"2002","journal-title":"Cardiovas Res"},{"key":"R56-5-20210208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2009.03.002","article-title":"The impairment of preconditioning-mediated cardioprotection in pathological conditions.","volume":"60","author":"Balakumar","year":"2009","journal-title":"Pharmacol Res"},{"key":"R57-5-20210208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3923\/tmr.2007.160.166","article-title":"Hyperhomocysteinemia and cardiovascular disorders: Is there a correlation?","volume":"2","author":"Balakumar","year":"2007","journal-title":"Trends Med Res"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00005344-200909000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T14:11:53Z","timestamp":1710598313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200909000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181b04cc5","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}